BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Genetown

  Targanta Therapeutics to Present at Canaccord Adams Anti-Infectives Investment Conference

  September 12, 2008

   · 

  1 min read
• Drug Development

  Acorda Therapeutics To Present Phase 3 Fampridine-SR Data at World Congress on Treatment and Research in Multiple Sclerosis Meeting

  September 12, 2008

   · 

  1 min read
• Genetown

  Thermo Fisher Scientific to Buy Back Its Common Stock

  September 12, 2008

   · 

  1 min read
• Business

  PharmaNet Development Group, Inc. Updates 2008 Guidance

  September 12, 2008

   · 

  1 min read
• Biotech Beach

  Company Profile for Allele Biotechnology

  September 12, 2008

   · 

  1 min read
• Drug Development

  Hollis-Eden Pharmaceuticals Inc. Reports Update on Autoimmunity Program with TRIOLEX(TM) (HE3286) at International Autoimmunity Meeting

  September 12, 2008

   · 

  1 min read
• Drug Development

  NPS Pharmaceuticals, Inc. to Report GATTEX(TM) Data at ESPEN, ACG, UEGW Congresses

  September 12, 2008

   · 

  1 min read
• Bio NC

  Laboratory Corporation of America Holdings’s Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

  September 12, 2008

   · 

  1 min read
• BioMidwest

  IDenta Corporation Stinger Drug Detection Kits Receive Official French Government Endorsement -- Dramatic Increase in Sales to French Law Enforcement Agencies Expected

  September 12, 2008

   · 

  1 min read
• Drug Development

  Transition Therapeutics Inc. Dose First Patient in Phase 2 Clinical Study of TT-223 in Type 2 Diabetes

  September 12, 2008

   · 

  2 min read